Magzter GOLD ile Sınırsız Olun

Magzter GOLD ile Sınırsız Olun

Sadece 9.000'den fazla dergi, gazete ve Premium hikayeye sınırsız erişim elde edin

$149.99
 
$74.99/Yıl

Denemek ALTIN - Özgür

Huge opportunities in generics, biologics and exports

Ingredients South Asia

|

November 1-15, 2025

THe therapeutic effects of medicines come from active pharmaceutical ingredients (APIs) that make them up.

- DR SOUMYA S. MORABAD

The API industry has changed from being a small part of the pharmaceutical industry to a major force behind innovation, self-sufficiency, and making healthcare available to everyone around the world. In 2025, the industry is going through a big change because there is more demand for generic drugs, biologics, and personalised treatments. At the same time, leaders in business and government are putting sustainability, digitalisation, and safe supply chains at the top of their lists.

Global API Market Outlook 2025

The global API market is expected to grow at a Compound Annual Growth Rate (CAGR) of 6-7% and reach more than US$250 billion by 2025. India and China together make more than 60% of the world's bulk drugs, making the Asia-Pacific region the most important for production. The US and Europe are the most innovative and have the most valuable APIs, but they still rely heavily on imports. Countries want to rely less on suppliers from a single source, so the market is moving towards more regional diversity. This growing demand means that both established and new API manufacturers will always have more opportunities.

Key Growth Drivers

Chronic Diseases: The rising burden of diabetes, cardiovascular disorders, cancer, and infectious diseases is pushing the demand for long-term treatments, boosting API requirements.

Generics and Biosimilar: With numerous blockbuster drugs losing patents, the generics market is thriving, and APIs are the backbone of this growth.

Expanding Healthcare Access: Initiatives by governments and NGOs to improve healthcare access in developing regions are widening the patient base.

Post-pandemic Preparedness: Covid-19 highlighted the need for secure pharmaceutical supplies, leading to greater investment in API capacity worldwide.

Opportunities in New Markets

Ingredients South Asia'den DAHA FAZLA HİKAYE

Ingredients South Asia

Ingredients South Asia

AI embedding intelligence at every stage of healthcare

ARTIFICIAL Intelligence (AI) is no longer a futuristic concept—it's a present-day force redefining how the world discovers, develops, and delivers medicines.Once viewed as a distant dream, AI has now become the catalyst for a scientific revolution, transforming pharmaceutical research into a faster, more precise, and more human-centered enterprise.

time to read

4 mins

November 16-30, 2025

Ingredients South Asia

Microplastics in packaged F&B spark health concerns

In a troubling shift from oceanic pollution to everyday meals, microplastics—tiny fragments of plastic less than five millimetres in diameter—are increasingly being found in packaged food and beverages.

time to read

4 mins

November 16-30, 2025

Ingredients South Asia

Imports of bulk drugs grew 2.6% in H1FY26

IMPORTS of bulk drugs and intermediates to India has reported a decline of 2.6% in the first half of the fiscal year 2025-26, as compared to a growth of 3.13% reported in the same period of previous fiscal year, on a year-over-year (YoY) basis.

time to read

1 mins

November 16-30, 2025

Ingredients South Asia

Ingredients South Asia

Ingredients that add fortification to F&B products

FOOD fortification is the well-established practice of deliberately adding essential micronutrients (vitamins, minerals, trace elements) to food or beverage products in order to improve their nutritional value and address public health micronutrient deficiencies.

time to read

4 mins

November 16-30, 2025

Ingredients South Asia

Ingredients South Asia

Paris beckons South Asia's F&B trailblazers

THE global food and beverage (F&B) ingredients calendar is counting down to a pivotal moment as Fi Europe (Food ingredients Europe), the flagship event of the Fi Global portfolio, prepares to host its landmark 30th edition at the Paris Expo Porte de Versailles from December 2-4, 2025.

time to read

4 mins

November 16-30, 2025

Ingredients South Asia

Ingredients South Asia

Ingredients industry stands at transformative crossroads

The food ingredients industry, a cornerstone of the global food supply chain, is currently experiencing a significant transformation.

time to read

4 mins

November 16-30, 2025

Ingredients South Asia

Export of bulk drugs grows over 8.3% in H1FY26

EXPORTS of bulk drugs and intermediates reported a growth of 8.33% in the first half of the current fiscal year on a YoY basis, reporting a trade surplus of almost $229 million for the period.

time to read

2 mins

November 16-30, 2025

Ingredients South Asia

Ingredients South Asia

Global food ingredients market valued at over $74 bn

IN 2025, the global food industry finds itself at a crossroads — balancing innovation, health awareness, sustainability, and regulatory compliance.

time to read

3 mins

November 16-30, 2025

Ingredients South Asia

Ingredients South Asia

Ingredients market fuelled by ongoing innovation

THE market for food ingredients worldwide is a sizable and expanding industry that includes a variety of goods and uses. In 2023, the market for speciality food ingredients was valued at $101.9 billion.

time to read

4 mins

November 16-30, 2025

Ingredients South Asia

Barentz' new distribution partnership with Chemian

BARENTZ has announced a new distribution partnership with Chemian Technology, best known for its Citrepel range of naturally based insect repellent active ingredients. Under this agreement, Barentz will distribute Chemian Technology's product range across the Asia Pacific region, effective immediately.

time to read

1 min

November 16-30, 2025

Listen

Translate

Share

-
+

Change font size